EFPIA states AI rules must “enable not hinder” pharma R&D
Drug Discovery World
APRIL 24, 2024
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has supported the use of artificial intelligence (AI) to deliver benefit for patients, life science companies and society, in response to the EU Artificial Intelligence (AI) Act.
Let's personalize your content